| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 08/09/2005 | US6926913 Tetraglycol as a solvent for molecular iodine in the preparation of a topical counter-irritant against skin burns |
| 08/09/2005 | US6926912 Metal compounds, mixed or sulphated, as phosphate binders |
| 08/09/2005 | CA2139865C Use of particles of a biocompatible, bioabsorbable calcium salt as active principle in the preparation of a medicament for local treatment of bone demineralizing diseases |
| 08/04/2005 | WO2005070461A2 Compositions of an anticonvulsant and an antipsychotic drug for affecting weight loss |
| 08/04/2005 | WO2005070438A1 Pharmaceutical composition comprising water depleted of heavy isotopes 0-17 and 0-18 |
| 08/04/2005 | WO2005070378A1 Tooth whitening composition |
| 08/04/2005 | WO2005070202A1 Antimicrobial surface preparation and method for producing the same |
| 08/04/2005 | WO2005070043A2 Methods for treating non-melanoma cancers with paba |
| 08/04/2005 | WO2005069962A2 Antimicrobial ceramic glaze |
| 08/04/2005 | WO2005060978A3 Polymetaphosphate based formulations for therapy of microcrystalline arthropathies |
| 08/04/2005 | WO2005053605A3 Therapeutic liposomes |
| 08/04/2005 | WO2005037259A3 Methods and compositions for the prevention or treatment of neoplasia comprising a cox-2 inhibitor in combination with an epidermal growth factor receptor antagonist |
| 08/04/2005 | WO2005023206A3 Silver-and zinc-containing body care agent |
| 08/04/2005 | WO2005010481A3 Preparation and use of gold glyconanoparticles |
| 08/04/2005 | US20050171063 Plasmodium falciparum parasitic growth inhibition; such as phosphono formic or acetic acid |
| 08/04/2005 | US20050171053 Producing zinc salt antimicrobial agents; precipitating lambda form in alcohol, soaking in metal salt, alcohol and water; separating complex, washing and drying |
| 08/04/2005 | US20050171030 Relieving symptoms of erectile dysfunction and attaining sexual wellness and health of the sexual vascular system with proanthocyanidins |
| 08/04/2005 | US20050170500 Methods for identifying risk of melanoma and treatments thereof |
| 08/04/2005 | US20050170019 Methods, compositions and devices for inducing stasis in cells |
| 08/04/2005 | US20050170018 Extract oily phase by cold press and solvent; use as nutritional supplements, in cosmetics |
| 08/04/2005 | US20050170015 thiocolchicine and an antiproliferative agent selected from paclitaxel, vinblastine, etoposide, camptothecin, cisplatin, amonafide; causing alkylation damage of DNA or affects topoisomerases or tubulin; anticarcinogenic agent |
| 08/04/2005 | US20050170014 Carbonyl iron pharmaceutical dosage forms for the treatment of iron-deficiency anemia |
| 08/04/2005 | US20050170013 disodium EDTA; sodium lauryl sulfate; sodium citrate; zinc chloride; and hydrogen peroxide as an oxidant blocks the inflammation chemical and biochemical pathway that leads to a dermatological inflammatory tissue reaction associated with insect bites, burns, diaper rash, jock itch, and other irritants |
| 08/04/2005 | US20050170003 amlodipine maleate, ethylcellulose, mannitol, or corn starch as a carrier, maleic acid, phosphoric acid sorbic acid or ascorbic acid as an acid to prevent the formation of N-(2-{[4-(2-chlorophenyl)-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydro-2-pyridyl]methoxy}ethyl)aspartic acid |
| 08/04/2005 | US20050170001 polyundecanolactam or polylaurolactam polyamide and 0.2 to 3% of a soluble ceramic in which silver ions are encapsulated; encapsulation protects silver ion from ultraviolet radiation and temperature; electrostatic powder coating or by fluidized-bed dip coating |
| 08/04/2005 | US20050169959 Medical implants and fibrosis-inducing agents |
| 08/04/2005 | US20050169958 Medical implants and fibrosis-inducing agents |
| 08/04/2005 | CA2553803A1 Therapeutic methods and pharmaceutical compositions for treating warts with tellurium compounds |
| 08/04/2005 | CA2553207A1 Compositions of an anticonvulsant and an antipsychotic drug for affecting weight loss |
| 08/04/2005 | CA2495839A1 Anti-photoaging cosmeceutical composition |
| 08/03/2005 | EP1558239A1 Combination comprising a cdk inhibitor and cisplatin |
| 08/03/2005 | EP1558228A1 Topical administration of basic antifungal compositions to treat fungal infections of the nails |
| 08/03/2005 | EP1558084A2 Treatment for hemorrhagic shock |
| 08/03/2005 | EP1558078A2 Acidified chlorite compositions containing nitrogenous stabilizers and systems and methods related thereto |
| 08/03/2005 | EP1207861B1 Treatment of fungal infections utilizing a fungal growth medium |
| 08/03/2005 | EP0639070B1 Use of borate-polyol complexes in ophthalmic compositions |
| 08/03/2005 | CN1649605A Use of topical compositions for the control of microbial diseases of the nail |
| 08/03/2005 | CN1649601A Difructose anhydride-containing composition and use thereof |
| 08/03/2005 | CN1649583A Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |
| 08/03/2005 | CN1649577A Preventing and/or treating cardiovascular disease and/or associated heart failure |
| 08/03/2005 | CN1649517A Soft drink replacer |
| 08/03/2005 | CN1649513A Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 08/03/2005 | CN1647798A Disposable bleaching water for removing black nevus and black nevus removing technology |
| 08/03/2005 | CN1212858C Chinese medicine with four integrated functions for treating hepatic disease |
| 08/03/2005 | CN1212848C L-histidine in ophthalmic solutions |
| 08/03/2005 | CN1212847C Improved ophthalmic and contact lens solutions containing forms of vitamin B |
| 08/02/2005 | US6924141 Inducing the effects of promoted signal transduction with protein and lithium chloride or mimicking via administration of agent that inhibits either catenin phosphorylation or kinase |
| 08/02/2005 | US6923991 Bactericide solution and method of making same |
| 08/02/2005 | US6923990 comprises silver thiosulfate-tri-hydroxymethyl aminomethane complex; improved solvent miscibility; catheters |
| 08/02/2005 | US6923987 Solid preparation for dialysis and process for producing the same |
| 08/02/2005 | CA2340927C Method for treating calcium borate ores to obtain useful boron compounds |
| 08/02/2005 | CA2248968C Nasal administration of agents for treatment of delayed onset emesis |
| 07/28/2005 | WO2005067970A1 Iron supplement and utilization of the same |
| 07/28/2005 | WO2005067947A1 Nonspecific anti-viral and anti-bacterial solution |
| 07/28/2005 | WO2005067946A1 Non-specific anti-viral and anti-bacterial (anti-microbial) solution |
| 07/28/2005 | WO2005067945A2 Use of a xenon/carbon monoxide mixture for the protection of cells |
| 07/28/2005 | WO2005055963A3 Decontamination formulation with sorbent additive |
| 07/28/2005 | WO2005051433B1 Method for treating human tumor cells with a newcastle disease virus strain and a chemotherapeutic agent |
| 07/28/2005 | WO2005041944A3 Methods and compositions for promoting axon regeneration and cell replacement therapy |
| 07/28/2005 | WO2005032234A3 Agent for reducing ill effects of acute alcohol intoxication |
| 07/28/2005 | WO2004064767A3 Nitric oxide inducing agents |
| 07/28/2005 | US20050165102 Improved bioavailability by complexing a drug such as metformin with an ionic moiety such as a fatty acid; e.g. metformin laurate; wrong claims attached to this publication |
| 07/28/2005 | US20050165039 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 07/28/2005 | US20050164395 Synthetic urine and method of manufacturing same |
| 07/28/2005 | US20050164267 Using caudal-1 gene (CDX-1) as diagnostic indicator of stomach or esophageal cancer; immunodiagnostics |
| 07/28/2005 | US20050163871 Caralluma extract products and processes for making the same |
| 07/28/2005 | US20050163868 mixtures of plant extracts, cellulose esters, sodium bicarbonate and silica, having improved disintegration and dissolution properties |
| 07/28/2005 | US20050163867 Composition and method of treating gastric ulcers in mammals |
| 07/28/2005 | US20050163865 Food supplement embodiments provide the human body nutritional supplements to intake certain neurotransmitter precursor substrates, thereby enabling patients of all ages to self-regulate their ability to quell perturbations to equilibrium and simultaneously to adverse effects |
| 07/28/2005 | US20050163864 Comprises vitamin C, vitamin E, vitamin A (beta-carotene), zinc oxide, and cupric oxide; for promotion of retinal health |
| 07/28/2005 | US20050163863 use of arsenic for treating autoimmune diseases, in particular autoimmune lymphoproliferative syndrome |
| 07/28/2005 | US20050163862 Suppressing cytokine secretion with such as sodium selenite; by the reduction in extra- and intracellular oxidative stress |
| 07/28/2005 | US20050163854 Antimicrobial composites, films, labelstocks and labels |
| 07/28/2005 | US20050163850 Administration of levodopa and carbidopa |
| 07/28/2005 | US20050163849 Compositions and dosage forms for enhanced absorption of iron |
| 07/28/2005 | US20050163848 complexed with transport moiety comprising a lauryl sulfate salt; complex provides an enhanced absorption of the drug in the lower gastrointestinal tract; to control seizures or neuropathic pain with once daily administration |
| 07/28/2005 | US20050163841 to controllably deliver orally a drug at a substantially zero order delivery rate a during a window; improved oral absorption |
| 07/28/2005 | US20050163817 Biomatrix structural containment and fixation systems and methods of use thereof |
| 07/28/2005 | US20050163811 highly effective, non-oily solution for facilitating hair growth that comprises a high concentration of Minoxidil, that is not cosmetically unattractive when applied to a treatment area and that does not cause skin irritation in the treatment area |
| 07/28/2005 | US20050163788 Prevention and treatment of amyloidogenic disease |
| 07/28/2005 | US20050163785 affect cell growth by blocking progression of the cell cycle in G2/M and their use in therapy of cancers which express the antigen |
| 07/28/2005 | US20050163759 Compositions and methods for ex vivo preservation of blood vessels for vascular grafts using inhibitors of type I and/or type II phosphodiesterases |
| 07/28/2005 | US20050163727 Topical, oral administration; mouthrinses; microbiocides; bactericides; prevents spread of pathogenic oral bacteria, toxins and endotoxins, and resultant inflammatory cytokines and mediators; cardiovascular disease, stroke, atherosclerosis |
| 07/28/2005 | US20050163707 Radio labelled monoclonal antibody human milk fat globule1, binds selectively to polymorphic epithelial mucin; Taxotere chemotherapeutic agent; administered in combination |
| 07/28/2005 | DE10361275A1 Influx nozzle e.g. for swimming pools, has hollow ball body made from two parts and are rotatable relative to each other around axis of rotation with each part having outlet for water jet |
| 07/28/2005 | DE102004014294A1 Composition containing mixed oxide that includes aluminum or magnesium and branched alkanoic acid, useful for control of microbes, e.g. treating acne or in cleaning compositions |
| 07/28/2005 | CA2552889A1 Iron supplement and utilization of the same |
| 07/27/2005 | EP1556073A2 Method and composition for preventing and treating solid tumors |
| 07/27/2005 | EP1556023A1 Nutritional or therapeutic compositions |
| 07/27/2005 | EP1556019A2 Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors |
| 07/27/2005 | EP1556008A1 Use of bases for the manufacture of a medicament in the treatment of different forms of inflammatory dermatosis |
| 07/27/2005 | EP1214063B1 Treating cancer using tetraethyl thiuram disulfide |
| 07/27/2005 | EP1143955B1 A COMBINATION OF FBPase INHIBITORS AND INSULIN SENSITIZERS FOR THE TREATMENT OF DIABETES |
| 07/27/2005 | EP1075268B1 Use of a fluoride ion vector for preparing a medicine for preventing or treating diseases associated with helicobacter pylori |
| 07/27/2005 | EP1009402B1 Compositions and use of benzamides as anti-inflammatory agents |
| 07/27/2005 | EP0981323B1 Desensitizing dentifrice having limited astringency |
| 07/27/2005 | CN1646568A Iron dextrin compounds for the treatment of iron deficiency anaemia |
| 07/27/2005 | CN1646164A Process for the preparation of a nutrient formulation |
| 07/27/2005 | CN1646146A Methods of treating vascular disease |
| 07/27/2005 | CN1646140A Use of a compound having the ability to release CO in preparation of pharmaceutical compositions for treatment of inflammation |